Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by chrispion May 12, 2021 3:37pm
137 Views
Post# 33184664

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:question for MBT123

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:question for MBT123Hey Twerp,
yes mistakes were made along the journey but I encourage you to stop living in the past. New management will get this across the finish line :)

I was a suffering Sernova Corp. shareholder for many, many years as they had many obstacles to climb on their journey too and in fact I watched it go to .27 (27 pennies - around where Bioasis is now) late last year (Dec/2020). I wasn't feeling too great about my investment at that point but I had researched the science and believed in what they had and in fact, I held my nose and bought even more shares despite "the market telling me I was an idiot for doing so".

Can you also believe that in March/2020 the share price was .10 (a dime)!

Well, guess what. Things changed 180 at the company with science data studies being released and that .27/share company went to $2.87 on Jan 19/2021
-->That's right, after releasing study results Sernova was more than a 10-bagger in less than 2 months.

How'd it feel to be selling Sernova when the share price was in the toilet, when most shareholders were frustrated/angry/depressed, when nearly all hope was gone at least according to the share price and chart it was, AND THEN see it rocket for 900+% gains in a few weeks.

Lesson to be learned: the market (and chart) is not always telling the true story that is about to unfold.
<< Previous
Bullboard Posts
Next >>